These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 20021320)

  • 1. Effect of second-generation antipsychotics on cognition: current issues and future challenges.
    Hill SK; Bishop JR; Palumbo D; Sweeney JA
    Expert Rev Neurother; 2010 Jan; 10(1):43-57. PubMed ID: 20021320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oculomotor and neuropsychological effects of antipsychotic treatment for schizophrenia.
    Hill SK; Reilly JL; Harris MS; Khine T; Sweeney JA
    Schizophr Bull; 2008 May; 34(3):494-506. PubMed ID: 17932088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cognition, schizophrenia and the effect of antipsychotics].
    Stip E
    Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?
    Goldberg TE; Goldman RS; Burdick KE; Malhotra AK; Lencz T; Patel RC; Woerner MG; Schooler NR; Kane JM; Robinson DG
    Arch Gen Psychiatry; 2007 Oct; 64(10):1115-22. PubMed ID: 17909123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia.
    van Veelen NM; Grootens KP; Peuskens J; Sabbe BG; Salden ME; Verkes RJ; Kahn RS; Sitskoorn MM
    Schizophr Res; 2010 Jul; 120(1-3):191-8. PubMed ID: 20493663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.
    Keefe RS; Silva SG; Perkins DO; Lieberman JA
    Schizophr Bull; 1999; 25(2):201-22. PubMed ID: 10416727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cognitive deficits in schizophrenia.
    Bowie CR; Harvey PD
    Curr Opin Investig Drugs; 2006 Jul; 7(7):608-13. PubMed ID: 16869112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting drug efficacy for cognitive deficits in schizophrenia.
    Hagan JJ; Jones DN
    Schizophr Bull; 2005 Oct; 31(4):830-53. PubMed ID: 16177277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment.
    Sharma T; Antonova L
    Psychiatr Clin North Am; 2003 Mar; 26(1):25-40. PubMed ID: 12683258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive effects of second-generation antipsychotics: current insights into neurochemical mechanisms.
    Fumagalli F; Frasca A; Racagni G; Riva MA
    CNS Drugs; 2009; 23(7):603-14. PubMed ID: 19552487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive effects and antipsychotic treatment.
    Kasper S; Resinger E
    Psychoneuroendocrinology; 2003 Jan; 28 Suppl 1():27-38. PubMed ID: 12504070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients.
    Yasui-Furukori N; Kaneda A; Sugawara N; Tomita T; Kaneko S
    J Psychopharmacol; 2012 Jun; 26(6):806-12. PubMed ID: 21616975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the effects of antipsychotics on cognition in schizophrenia. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():35-40. PubMed ID: 9766618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of cognitive dysfunction after treatment with second-generation antipsychotics.
    Weiss E; Kemmler G; Fleischhacker WW
    Arch Gen Psychiatry; 2002 Jun; 59(6):572-3; author reply 573-5. PubMed ID: 12044210
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically.
    Brown JW; Rueter LE; Zhang M
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():53-62. PubMed ID: 24269664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia.
    Weiss EM; Bilder RM; Fleischhacker WW
    Psychopharmacology (Berl); 2002 Jun; 162(1):11-7. PubMed ID: 12107611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative.
    Carter CS; Barch DM
    Schizophr Bull; 2007 Sep; 33(5):1131-7. PubMed ID: 17630405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment in late life schizophrenia: a suitable case for treatment?
    Howard R
    Int J Geriatr Psychiatry; 1998 Jun; 13(6):400-4. PubMed ID: 9658275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy of cognitive deficits in schizophrenia.
    Opler LA; Medalia A; Opler MG; Stahl SM
    CNS Spectr; 2014 Apr; 19(2):142-56. PubMed ID: 24229725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.